These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6265111)

  • 1. Kinetically scheduled therapy for extensive small-cell lung cancer.
    Clamon GH; McFadden DB; Weisenfeld M; Bell S
    Cancer Clin Trials; 1981; 4(2):159-62. PubMed ID: 6265111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
    Lee YC; McCrystal MR; Christmas TI
    N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot study with weekly chemotherapy for patients with extensive small cell lung cancer: an Eastern Cooperative Oncology Group Study (PA586).
    Yuen AR; Fuks JZ; Ettinger DS; Chang AY; Ruckdeschel JC; Phan SC; Blum RH
    Cancer J Sci Am; 2000; 6(1):34-9. PubMed ID: 10696737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
    Hainsworth JD; Greco FA
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small cell anaplastic carcinoma of the lung. The Cancer and Leukemia Group B Experience.
    Chahinian AP; Comis RL; Maurer LH; Pajak TF
    Bull Cancer; 1982; 69(1):79-82. PubMed ID: 6280794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations.
    Aisner J; Whitacre M; Van Echo DA; Wiernik PH
    Cancer Treat Rep; 1982 Feb; 66(2):221-30. PubMed ID: 6275987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European organization for research and treatment of cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancer.
    Ardizzoni A; Manegold C; Debruyne C; Gaafar R; Buchholz E; Smit EF; Lianes P; ten Velde G; Bosquee L; Legrand C; Neumaier C; King K;
    Clin Cancer Res; 2003 Jan; 9(1):143-50. PubMed ID: 12538462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate in the chemotherapy of lung cancer.
    Smyth JF; Ford HT
    Cancer Treat Rep; 1981; 65 Suppl 1():161-3. PubMed ID: 6275986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclophosphamide, vincristine, lomustine, cisplatin, and doxorubicin in the treatment of non-small cell lung cancer.
    Pearlman NW; Meyers TJ; Siebert PE; Wallner SF; Carson SD; Campbell DN; Johnson FB; Kennaugh R; Rempel P
    Cancer Treat Rep; 1983 Apr; 67(4):375-6. PubMed ID: 6303587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy of small cell carcinomas of the lung].
    Flicker M; Neumann M
    Wien Med Wochenschr; 1983 Aug; 133(15-16):397-402. PubMed ID: 6314680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adriamycin in the combined chemotherapy of small-cell lung cancer].
    Perevodchikova NI; Bychkov MB; Ausekar BV
    Antibiotiki; 1983 Aug; 28(8):628-32. PubMed ID: 6314882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of a combination chemotherapy "VEMA" consisting of vincristine, cyclophosphamide, methotrexate and ACNU in the treatment of small cell bronchogenic carcinoma].
    Kojima T; Ito Y; Nakanishi F; Sugihara T; Nagata K; Kamiya O; Ohara K; Hoshino A
    Gan To Kagaku Ryoho; 1983 Jun; 10(6):1491-6. PubMed ID: 6307169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palliative therapy: extensive small cell lung cancer.
    Loehrer PJ
    Semin Oncol; 1995 Apr; 22(2 Suppl 3):40-4. PubMed ID: 7537903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis.
    Strauss GM; Lynch TJ; Elias AD; Jacobs C; Herbst R; Leong T; Lynch C; Kwiatkowski DJ; Carey RW; Grossbard ML; Skarin AT
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-73-S12-80. PubMed ID: 9331127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemotherapy in cancer of the lung].
    Gütz S
    MMW Fortschr Med; 2006 Jun; 148(22):33-4. PubMed ID: 16821578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of topotecan to standard cisplatin/etoposide combination in patients with extended stage small cell lung carcinoma.
    Tas F; Derin D; Guney N; Camlica H; Aydiner A; Topuz E
    Lung Cancer; 2007 Jul; 57(1):79-83. PubMed ID: 17383768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of patients with limited-stage small cell lung cancer treated with individualized chemotherapy selected by in vitro drug sensitivity testing.
    Cortazar P; Gazdar AF; Woods E; Russell E; Steinberg SM; Williams J; Ihde DC; Johnson BE
    Clin Cancer Res; 1997 May; 3(5):741-7. PubMed ID: 9815744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topotecan and etoposide as first-line therapy for extensive disease small cell lung cancer: a phase II trial of a platinum-free regimen.
    Reck M; Groth G; Buchholz E; Goetz E; Gatzemeier U; Manegold C
    Lung Cancer; 2005 Jun; 48(3):409-13. PubMed ID: 15893010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etoposide (VP-16) containing combination chemotherapy for treatment of patients with small cell lung cancer.
    Behera D; Jindal SK; Sharma SC
    Indian J Chest Dis Allied Sci; 1995; 37(1):15-9. PubMed ID: 16892733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sequential chemotherapy and radiotherapy modalities in small cell lung carcinoma. Preliminary results].
    Le Chevalier T; Arriagada R; Pico JL; Rouësse J; Hayat M; Duroux P; Baldeyrou P; Homasson JP
    Bull Cancer; 1982; 69(1):98-101. PubMed ID: 6280797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.